Thirty-day outcome after transcatheter aortic valve implantation compared with surgical valve replacement in patients with high-risk aortic stenosis: A matched comparison

Coronary Artery Disease

Volumn 22, Issue 8, 2011, Pages 595-600

  Stöhr, Robert ^a   Dohmen, Guido ^a   Herpertz, Ralf ^a   Brehmer, Kathrin ^a   Aktug, Ömer ^a   Koos, Ralph ^a   Altiok, Ertunc ^a   Stegemann, Emilia ^a   Autschbach, Rüdiger ^a   Marx, Nikolaus ^a   Hoffmann, Rainer ^a  

^a RWTH AACHEN UNIVERSITY   (Germany)

Author keywords

Aortic stenosis; aortic valve surgery; transcatheter aortic valve implantation

Indexed keywords

AGED; AORTA STENOSIS; AORTA VALVE REPLACEMENT; ARTICLE; CARDIOVASCULAR RISK; DIALYSIS; FEMALE; FOLLOW UP; GROUPS BY AGE; HIGH RISK PATIENT; HUMAN; INTENSIVE CARE UNIT; INTERMETHOD COMPARISON; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PACEMAKER; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; RENAL REPLACEMENT THERAPY; RETROSPECTIVE STUDY; STROKE; SURGICAL MORTALITY; TRANSCATHETER AORTIC VALVE IMPLANTATION;

AGE FACTORS; AGED; AGED, 80 AND OVER; AORTIC VALVE STENOSIS; CARDIAC CATHETERIZATION; CHI-SQUARE DISTRIBUTION; FEMALE; GERMANY; HEART VALVE PROSTHESIS IMPLANTATION; HUMANS; INTENSIVE CARE UNITS; KAPLAN-MEIER ESTIMATE; KIDNEY DISEASES; LENGTH OF STAY; MALE; MATCHED-PAIR ANALYSIS; ODDS RATIO; PATIENT SELECTION; PROPORTIONAL HAZARDS MODELS; RENAL DIALYSIS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; STROKE; TIME FACTORS; TREATMENT OUTCOME;

EID: 81855217567     PISSN: 09546928     EISSN: 14735830     Source Type: Journal    
DOI: 10.1097/MCA.0b013e32834d335e     Document Type: Article

References (21)

1. Ross J Jr, Braunwald E. Aortic stenosis. Circulation 1968; 38:61-67.
2. Otto CM, Pearlman AS, Gardner CL. Hemodynamic progression of aortic stenosis in adults assessed by Doppler echocardiography. JAm Coll Cardiol1989; 13:545-550. (Pubitemid 19073920)
3. Bonow RO, Carabello BA, Chatterjee K. ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: executive summary. Circulation 2006; 114:450-527.
4. Vahanian A, Baumgartner H, Bax J, Butchart E, Dion R, Filippatos G, et al. Guidelines on the management of valvular heart disease: the Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology. Eur Heart J 2007; 28:230-268. (Pubitemid 46276943)
5. Cribier A, Eltchaninoff H, Bash A, Borenstein N, Tron C, Bauer F, et al. Percutaneous transcatheter implantation of an aortic valve prosthesis for calcific aortic stenosis: first human case description. Circulation 2002; 106:3006-3008. (Pubitemid 35440280)
6. Grube E, Laborde JC, Gerckens U, Felderhoff T, Sauren B, Buellesfeld L, et al. Percutaneous implantation of the Core Valve self-expanding valve prosthesis in high-risk patients with aortic valve disease: the Siegburg first-in-man study. Circulation 2006; 114:1616-1624. (Pubitemid 44547432)
7. Webb JG, Chandavimol M, Thompson CR, Ricci DR, Carere RG, Munt BI, et al. Percutaneous aortic valve implantation retrograde from the femoral artery. Circulation 2006; 113:842-850.
8. Vahanian A, Alfieri O, Al-Attar N, Antunes M, Bax J, Cormier B, et al. European Association of Cardio-Thoracic Surgery. European Society of Cardiology; European Association of Percutaneous Cardiovascular Interventions. Transcatheter valve implantation for patients with aortic stenosis: a position statement from the European Association of Cardio-Thoracic Surgery (EACTS) and the European Society of Cardiology (ESC), in collaboration with the European Association of Percutaneous Cardiovascular Interventions (EAPCI). Eur Heart J2008; 29:1463-1470. (Pubitemid 351806497)
9. Grube E, Schuler G, Buellesfeld L, Gerckens U, Linke A,Wenaweser P, etal. Percutaneous aortic valve replacement for severe aortic stenosis in high-risk patients using the second- and current third-generation self-expanding Core Valve prosthesis: device success and 30-day clinical outcome. J Am Coll Cardiol 2007; 50:69-76. (Pubitemid 46970878)
10. Webb JG, Altwegg L, Boone RH, Cheung A, Ye J, Lichtenstein S, et al. Transcatheter aortic valve implantation: impact on clinical and valve-related outcomes. Circulation 2009; 119:3009-3016.
11. Thomas M, Schymik G, Walther T, Himbert D, Lefèvre T, Treede H, et al. Thirty-day results of the SAPIEN Aortic Bioprosthesis European Outcome (SOURCE) registry. Circulation 2010; 122:62-69.
12. Himbert D, Descoutures F, Al-Attar N, Iung B, Ducrocq G, Détaint D, et al. Results of transfemoral or transapical aortic valve implantation following a uniform assessment in high-risk patients with aortic stenosis. J Am Coll Cardiol 2009; 54:303-311.
13. Piazza N, Grube E, Gerckens U, den Heijer P, Linke A, Luha O, et al. Procedural and 30-day outcomes following transcatheter aortic valve implantation using thethird generation (18Fr) Core Valve revalving system: results from the multi-centre, expanded evaluation registry 1-year following CE mark approval. Euro Intervention 2008; 4:242-249.
14. Roques F, Nashef SA, Michel P. Risk factors for early mortality after valve surgery in Europe in the 1990s: lessons from the Euro SCORE pilot program. J Heart Valve Dis 2001; 10:572-577.
15. Leon MB, Smith CR, Mack M, Miller DC, Moses JW, Svensson LG, et al.; for the PARTNERTrial Investigators.. Transcatheteraortic-valve implantation for aortic stenosis in patientswho cannot undergosurgery. N Engl J Med2010; 363:1597-1607.
16. Zahn R, Gerckens U, Grube E. Transcatheter aortic valve implantation: first results from a multi-centre real-world registry. Eur Heart J 2011; 32: 198-204.
17. Ghanem A, Müller A, Nähle CP, Kocurek J, Werner N, Hammerstingl C, et al. Risk and fate of cerebral embolism after transfemoral aortic valve implantation: a prospective pilot study with diffusion-weighted magnetic resonance imaging. JAm Coll Cardiol 2010; 55: 1427-1432.
18. Webb JG, Pasupati S, Humphries K,Thompson C, Altwegg L, Moss R, etal. Percutaneous transarterial aortic valve replacement in selected high-high-risk patients with aortic stenosis. Circulation 2007; 116:755-763. (Pubitemid 47255993)
19. Kahlert P, Knipp SC, Schlamann M,Thielmann M, Al-Rashid F, Weber M, et al. Silent and apparent cerebral ischemia after percutaneous transfemoral aortic valve implantation: a diffusion-weighted magnetic resonance imaging study. Circulation 2010; 121:870-878.
20. Grube E, Buellesfeld L, Mueller R, Sauren B, Zickmann B, Nair D, et al. Progress and current status of percutaneous aortic valve replacement: results of three device generations of the Core Valve Revalving system. Circ Cardiovasc Intervent 2008; 1:167-175.
21. Ben-Dor I, Pichard AD, Gonzales MA. Correlates and causes of death in patients with severe symptomatic aortic stenosis who are not eligible to participate in a clinical trial of transcatheter aortic valve implantation. Circulation 2010; 122:S37-S42.